Mycenax is a devoted CDMO company that has extensive experiences in developing biologics, ranging from small peptides, fusion proteins, and monoclonal antibodies. The expertise of Mycenax includes cell line development (CHO, Sp2/0, E. coli), process development, formulation, analytical methods, GMP manufacturing and fill-finish. We provide time- and cost-efficient services for customers from the world.